05.05.2010 • News

Evonik Seeks €1.5 Billion Loan Refinancing

German conglomerate Evonik said on Wednesday it was seeking a €1.5 billion loan to replace a €2.25 billion loan maturing next March.

The deal was launched on April 23 and expected to close in June, the company told Reuters LPC, adding the financing was split into three €500 million  revolving credit facilities bearing two, three and five-year maturities.

Evonik said a large core of relationship banks had committed to the financing as mandated lead arrangers and bookrunners. A selected group of close relationship banks have been invited to join the transaction in general syndication, it said.

A banking source said the new loan was being co-ordinated by Deutsche Bank alongside 15 banks. The financing, which is being conducted at the operating company level, does not affect the €1.25 billion non-standard LBO financing arranged in 2008 that backed private equity firm CVC's acquisition of a minority stake in the business, a second banking source said, adding that financing still has three years to run.

In December, Evonik said it planned to split off its real estate and energy units over coming years to emerge as a specialty chemicals company.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Free Virtual Event

Batteries and Hydrogen: Competitors or Partners?
CHEManager Spotlight

Batteries and Hydrogen: Competitors or Partners?

17 September 2026 | Reserve your spot to learn where solid-state batteries and green hydrogen are headed—and how leading teams are turning them into scalable energy storage solutions.

most read